Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis

International Journal of Infectious Diseases

Volumn 16, Issue 12, 2012, Pages

  Hong, Ji Young ^a   Jung, Gyeong Seo ^a   Kim, Hyunjung ^a   Kim, Young Mi ^a   Lee, Hye Jon ^a   Cho, Sang Nae ^a   Kim, Se Kyu ^a   Chang, Joon ^a   Kang, Young Ae ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Biomarker; Diagnosis; IP 10; Tuberculosis

Indexed keywords

ANTIGEN; ANTIGEN TB7.7; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOSTIMULATION; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MALE; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; QUANTIFERON TB GOLD IN TUBE ASSAY; SERODIAGNOSIS; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CXCL10; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; REPUBLIC OF KOREA; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84869229752     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.07.013     Document Type: Article

References (26)

1. WHO global tuberculosis control report 2010. Summary. Cent Eur J Public Health 2010;18:237.
2. Detjen A.K., Keil T., Roll S., Hauer B., Mauch H., Wahn U., et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007, 45:322-328.
3. Mandalakas A.M., Hesseling A.C., Chegou N.N., Kirchner H.L., Zhu X., Marais B.J., et al. High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 2008, 12:417-423.
4. Lange C., Pai M., Drobniewski F., Migliori G.B. Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly?. Eur Respir J 2009, 33:1250-1253.
5. Ruhwald M., Bodmer T., Maier C., Jepsen M., Haaland M.B., Eugen-Olsen J., et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 2008, 32:1607-1615.
6. Ruhwald M., Bjerregaard-Andersen M., Rabna P., Kofoed K., Eugen-Olsen J., Ravn P. CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect 2007, 9:806-812.
7. Whittaker E., Gordon A., Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?. PLoS One 2008, 3:e3901.
8. Lighter J., Rigaud M., Huie M., Peng C.H., Pollack H. Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. Int J Tuberc Lung Dis 2009, 13:731-736.
9. Ruhwald M., Dominguez J., Latorre I., Losi M., Richeldi L., Pasticci M.B., et al. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb) 2011, 91:260-267.
10. Ferrero E., Biswas P., Vettoretto K., Ferrarini M., Uguccioni M., Piali L., et al. Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gammadelta cells. Immunology 2003, 108:365-374.
11. Okamoto M., Kawabe T., Iwasaki Y., Hara T., Hashimoto N., Imaizumi K., et al. Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions. J Lab Clin Med 2005, 145:88-93.
12. Goletti D., Raja A., Syed Ahamed Kabeer B., Rodrigues C., Sodha A., Carrara S., et al. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?. PLoS One 2010, 5:e12577.
13. Kabeer B.S., Sikhamani R., Raja A. Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS 2010, 24:323-325.
14. Azzurri A., Sow O.Y., Amedei A., Bah B., Diallo S., Peri G., et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 2005, 7:1-8.
15. Chen D.Y., Shen G.H., Chen Y.M., Chen H.H., Lin C.C., Hsieh C.W., et al. Interferon-inducible protein-10 as a marker to detect latent and active tuberculosis in rheumatoid arthritis. Int J Tuberc Lung Dis 2011, 15:192-200.
16. Yassin M.A., Petrucci R., Garie K.T., Harper G., Arbide I., Aschalew M., et al. Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas?. PLoS One 2011, 6:e23733.
17. Aabye M.G., Ruhwald M., Praygod G., Jeremiah K., Faurholt-Jepsen M., Faurholt-Jepsen D., et al. Potential of interferon-gamma-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients. Eur Respir J 2010, 36:1488-1490.
18. Ruhwald M., Ravn P. Biomarkers of latent TB infection. Expert Rev Respir Med 2009, 3:387-401.
19. Narumi S., Takeuchi T., Kobayashi Y., Konishi K. Serum levels of IFN-inducible protein-10 relating to the activity of systemic lupus erythematosus. Cytokine 2000, 12:1561-1565.
20. Nagayama K., Enomoto N., Miyasaka Y., Kurosaki M., Chen C.H., Sakamoto N., et al. Overexpression of interferon gamma-inducible protein 10 in the liver of patients with type I autoimmune hepatitis identified by suppression subtractive hybridization. Am J Gastroenterol 2001, 96:2211-2217.
21. Brightling C.E., Ammit A.J., Kaur D., Black J.L., Wardlaw A.J., Hughes J.M., et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 2005, 171:1103-1108.
22. Villagomez M.T., Bae S.J., Ogawa I., Takenaka M., Katayama I. Tumour necrosis factor-alpha but not interferon-gamma is the main inducer of inducible protein-10 in skin fibroblasts from patients with atopic dermatitis. Br J Dermatol 2004, 150:910-916.
23. Goletti D., Raja A., Ahamed Kabeer B.S., Rodrigues C., Sodha A., Butera O., et al. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J Infect 2010, 61:133-143.
24. Su W.L., Perng W.C., Huang C.H., Yang C.Y., Wu C.P., Chen J.H. Association of reduced tumor necrosis factor alpha, gamma interferon, and interleukin-1beta (IL-1beta) but increased IL-10 expression with improved chest radiography in patients with pulmonary tuberculosis. Clin Vaccine Immunol 2010, 17:223-231.
25. Syed Ahamed Kabeer B., Raman B., Thomas A., Perumal V., Raja A. Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One 2010, 5:e9051.
26. Frahm M., Goswami N.D., Owzar K., Hecker E., Mosher A., Cadogan E., et al. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb) 2011, 91:250-256.